Published in Kidney Int on October 01, 2004
Mayo Clinic/Renal Pathology Society Consensus Report on Pathologic Classification, Diagnosis, and Reporting of GN. J Am Soc Nephrol (2015) 1.08
Anti-glomerular basement membrane antibody disease in Japan: part of the nationwide rapidly progressive glomerulonephritis survey in Japan. Clin Exp Nephrol (2008) 1.02
Anti-neutrophil cytoplasmic (ANCA) and anti-glomerular basement membrane (GBM) autoantibodies in necrotizing and crescentic glomerulonephritis. Semin Immunopathol (2007) 1.01
Microscopic polyangiitis. Rheum Dis Clin North Am (2010) 0.99
Anti-hLAMP2-antibodies and dual positivity for anti-GBM and MPO-ANCA in a patient with relapsing pulmonary-renal syndrome. BMC Nephrol (2011) 0.94
Dual myeloperoxidase-antineutrophil cytoplasmic antibody- and antiglomerular basement membrane antibody-positive cases associated with prior pulmonary fibrosis: a report of four cases. Clin Exp Nephrol (2011) 0.88
Pulmonary renal syndrome in a child with coexistence of anti-neutrophil cytoplasmic antibodies and anti-glomerular basement membrane disease: case report and literature review. BMC Nephrol (2013) 0.87
Thrombotic thrombocytopenic purpura in a patient with rapidly progressive glomerulonephritis with both anti-glomerular basement membrane antibodies and myeloperoxidase anti-neutrophil cytoplasmic antibodies. Clin Exp Nephrol (2010) 0.85
Characteristics and outcome of crescentic glomerulonephritis in patients with both antineutrophil cytoplasmic antibody and anti-glomerular basement membrane antibody. Clin Rheumatol (2013) 0.84
Chapter 14: Anti-glomerular basement membrane antibody glomerulonephritis. Kidney Int Suppl (2011) (2012) 0.83
Update on crescentic glomerulonephritis. Semin Immunopathol (2014) 0.82
Wegener granulomatosis. Proc (Bayl Univ Med Cent) (2006) 0.81
Goodpasture's Syndrome and p-ANCA Associated Vasculitis in a Patient of Silicosiderosis: An Unusual Association. Case Rep Pulmonol (2014) 0.80
Hemophagocytic lymphohistiocytosis in a patient with Goodpasture's syndrome: a rare clinical association. Am J Case Rep (2014) 0.79
Sequential occurrence of anti-glomerular basement membrane disease 9 years after anti-neutrophil cytoplasmic antibody-associated vasculitis. Oxf Med Case Reports (2016) 0.79
An 80-year-old female with double positive disease: Case report and brief review of literature. Am J Case Rep (2013) 0.79
Necrotizing RPGN with linear anti IgG deposits in a patient with history of granulomatosis with polyangiitis: a case report. Int J Nephrol Renovasc Dis (2014) 0.79
Spatial and Temporal Clustering of Anti-Glomerular Basement Membrane Disease. Clin J Am Soc Nephrol (2016) 0.77
The difficulty in considering modifiable pathology risk factors in children with IgA nephropathy: crescents and timing of renal biopsy. Pediatr Nephrol (2014) 0.77
Autoantibodies against Linear Epitopes of Myeloperoxidase in Anti-Glomerular Basement Membrane Disease. Clin J Am Soc Nephrol (2016) 0.76
Pauci-Immune Crescentic Glomerulonephritis: An ANCA-Associated Vasculitis. Biomed Res Int (2015) 0.76
Anti-glomerular basement membrane disease: Case series from a tertiary center in North India. Indian J Nephrol (2017) 0.75
Atypical anti-glomerular basement membrane disease: lessons learned. Clin Kidney J (2016) 0.75
Aortic valve replacement in a patient with MPO-ANCA-positive Goodpasture disease. Surg Case Rep (2016) 0.75
Clustering of Anti-GBM Disease: Clues to an Environmental Trigger? Clin J Am Soc Nephrol (2016) 0.75
Pre-existing chronic interstitial pneumonia is a poor prognostic factor of Goodpasture's syndrome: a case report and review of the literature. J Med Case Rep (2017) 0.75
A case report of the anti-glomerular basement membrane glomerulonephritis with mesangial IgA deposition. CEN Case Rep (2012) 0.75
Propylthiouracil-associated rapidly progressive crescentic glomerulonephritis with double positive anti-glomerular basement membrane and antineutrophil cytoplasmic antibody: the first case report. CEN Case Rep (2014) 0.75
AP-VAS 2012 case report: anti-glomerular basement membrane disease with high titer of myeloperoxidase anti-neutrophil cytoplasmic antibody-an autopsy case report. CEN Case Rep (2013) 0.75
Coexistence of Anti-Glomerular Basement Membrane Antibodies and Anti-Neutrophil Cytoplasmic Antibodies in a Child With Human Leukocyte Antigen Susceptibility and Detailed Antibody Description: A Case Report. Medicine (Baltimore) (2015) 0.75
Rapidly progressive glomerulonephritis due to coexistent anti-glomerular basement membrane disease and fibrillary glomerulonephritis. Clin Kidney J (2015) 0.75
Spectrum of glomerular diseases causing acute kidney injury; 25 years experience from a single center. J Renal Inj Prev (2015) 0.75
ANCA Glomerulonephritis and Vasculitis. Clin J Am Soc Nephrol (2017) 0.75
Anti-Glomerular Basement Membrane Disease. Clin J Am Soc Nephrol (2017) 0.75
Renal-limited vasculitis with elevated levels of multiple antibodies. CEN Case Rep (2017) 0.75
A case of PR3-ANCA-positive anti-GBM disease associated with intrarenal arteritis and thrombotic microangiopathy. CEN Case Rep (2016) 0.75
[Role of plasmapheresis and immunoadsorption in salvage therapy of rheumatological diseases]. Z Rheumatol (2016) 0.75
Effectiveness of Plasmapheresis in a Patient with Anti-glomerular Basement Membrane Antibody Glomerulonephritis with Advanced Kidney Dysfunction. Intern Med (2017) 0.75
Antibodies against linear epitopes on Goodpasture autoantigen in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis. Clin Rheumatol (2017) 0.75
Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans. Nature (2006) 9.30
Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med (2012) 6.93
Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial. Ann Intern Med (2009) 6.61
Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol (2007) 6.13
FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity. Nat Genet (2007) 5.93
Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis. Lancet (2010) 3.74
Histopathologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol (2010) 3.48
Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study. Am J Kidney Dis (2003) 2.40
Prolonged disease-free remission following rituximab and low-dose cyclophosphamide therapy for renal ANCA-associated vasculitis. Nephrol Dial Transplant (2011) 2.03
Bone marrow-derived cells contribute to podocyte regeneration and amelioration of renal disease in a mouse model of Alport syndrome. Stem Cells (2006) 1.90
Antineutrophil cytoplasm antibodies directed against myeloperoxidase augment leukocyte-microvascular interactions in vivo. Blood (2005) 1.86
Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitis. Rheumatology (Oxford) (2011) 1.79
The changing profile of acute tubulointerstitial nephritis. Nephrol Dial Transplant (2004) 1.73
Interferon-beta reduces proteinuria in experimental glomerulonephritis. J Am Soc Nephrol (2007) 1.63
Rituximab is effective in the treatment of refractory ophthalmic Wegener's granulomatosis. Arthritis Rheum (2009) 1.59
Effect of L-carnitine administration on erythrocyte survival in haemodialysis patients. Nephrol Dial Transplant (2006) 1.46
Serum IL-17 and IL-23 levels and autoantigen-specific Th17 cells are elevated in patients with ANCA-associated vasculitis. Nephrol Dial Transplant (2010) 1.46
Goodpasture's disease in the absence of circulating anti-glomerular basement membrane antibodies as detected by standard techniques. Am J Kidney Dis (2002) 1.42
Drug insight: rituximab in renal disease and transplantation. Nat Clin Pract Nephrol (2006) 1.41
Non-hepatitis virus associated mixed essential cryoglobulinemia. Kidney Int (2009) 1.40
Jund is a determinant of macrophage activation and is associated with glomerulonephritis susceptibility. Nat Genet (2008) 1.31
Oral cholecalciferol decreases albuminuria and urinary TGF-β1 in patients with type 2 diabetic nephropathy on established renin-angiotensin-aldosterone system inhibition. Kidney Int (2011) 1.24
Urinary monocyte chemoattractant protein-1 (MCP-1) and connective tissue growth factor (CCN2) as prognostic markers for progression of diabetic nephropathy. Cytokine (2009) 1.23
Experimental autoimmune vasculitis: an animal model of anti-neutrophil cytoplasmic autoantibody-associated systemic vasculitis. Am J Pathol (2009) 1.21
Crescentic glomerulonephritis: new aspects of pathogenesis. Semin Nephrol (2011) 1.18
Regulation by CD25+ lymphocytes of autoantigen-specific T-cell responses in Goodpasture's (anti-GBM) disease. Kidney Int (2003) 1.15
Interstitial lung disease and ANCA-associated vasculitis: a retrospective observational cohort study. Rheumatology (Oxford) (2011) 1.12
Chances of renal recovery for dialysis-dependent ANCA-associated glomerulonephritis. J Am Soc Nephrol (2007) 1.10
Therapeutic effect of anti-TNF-alpha antibodies in an experimental model of anti-neutrophil cytoplasm antibody-associated systemic vasculitis. J Am Soc Nephrol (2005) 1.09
P2X7 deficiency attenuates renal injury in experimental glomerulonephritis. J Am Soc Nephrol (2009) 1.08
Antibody blockade of TNF-alpha reduces inflammation and scarring in experimental crescentic glomerulonephritis. Kidney Int (2005) 1.07
Genes expressed by both mesangial cells and bone marrow-derived cells underlie genetic susceptibility to crescentic glomerulonephritis in the rat. J Am Soc Nephrol (2007) 1.07
Rituximab in refractory ophthalmic Wegener's granulomatosis: PR3 titers may predict relapse, but repeat treatment can be effective. Ophthalmology (2011) 1.07
Urinary monocyte chemoattractant protein-1 (MCP-1) is a marker of active renal vasculitis. Nephrol Dial Transplant (2004) 1.07
Increased expression of the pro-apoptotic ATP-sensitive P2X7 receptor in experimental and human glomerulonephritis. Nephrol Dial Transplant (2006) 1.06
Membranous glomerulonephritis associated with follicular B-cell lymphoma and subepithelial deposition of IgG1-kappa paraprotein. Nephron Clin Pract (2003) 1.05
Diffuse alveolar haemorrhage in ANCA-associated vasculitis. Intern Med (2013) 1.05
Intravenous cyclophosphamide and plasmapheresis in dialysis-dependent ANCA-associated vasculitis. Clin J Am Soc Nephrol (2012) 1.05
Inhibition of p38 mitogen-activated protein kinase is effective in the treatment of experimental crescentic glomerulonephritis and suppresses monocyte chemoattractant protein-1 but not IL-1beta or IL-6. J Am Soc Nephrol (2007) 1.01
Regulation of myeloperoxidase-specific T cell responses during disease remission in antineutrophil cytoplasmic antibody-associated vasculitis: the role of Treg cells and tryptophan degradation. Arthritis Rheum (2010) 1.00
Anti-CD8 monoclonal antibody therapy is effective in the prevention and treatment of experimental autoimmune glomerulonephritis. J Am Soc Nephrol (2002) 1.00
Leptin-deficient mice are protected from accelerated nephrotoxic nephritis. Am J Pathol (2004) 0.99
DNA adducts and p53 mutations in a patient with aristolochic acid-associated nephropathy. Am J Kidney Dis (2004) 0.99
Genetic loci modulate macrophage activity and glomerular damage in experimental glomerulonephritis. J Am Soc Nephrol (2010) 0.99
Shining a LAMP on pauci-immune focal segmental glomerulonephritis. Kidney Int (2009) 0.96
Leukocyte and serum S100A8/S100A9 expression reflects disease activity in ANCA-associated vasculitis and glomerulonephritis. Kidney Int (2013) 0.96
The evolution of crescentic nephritis and alveolar haemorrhage following induction of autoimmunity to glomerular basement membrane in an experimental model of Goodpasture's disease. J Pathol (2003) 0.95
Protein load impairs factor H binding promoting complement-dependent dysfunction of proximal tubular cells. Kidney Int (2009) 0.93
Nasal administration of recombinant rat alpha3(IV)NC1 prevents the development of experimental autoimmune glomerulonephritis in the WKY rat. J Am Soc Nephrol (2005) 0.93
Management of ANCA-associated vasculitis: Current trends and future prospects. Ther Clin Risk Manag (2010) 0.93
P2X7 receptor-mediated Nlrp3-inflammasome activation is a genetic determinant of macrophage-dependent crescentic glomerulonephritis. J Leukoc Biol (2012) 0.92
Commentary: Iloprost for cholesterol emboli syndrome. BMJ (2002) 0.92
Glomerulonephritis due to antineutrophil cytoplasm antibody-associated vasculitis: an update on approaches to management. Nephrology (Carlton) (2005) 0.92
Pulmonary-renal syndrome: a life threatening but treatable condition. Postgrad Med J (2013) 0.91
Proteinase-3 antineutrophil cytoplasm antibody positivity in patients without primary systemic vasculitis. J Clin Rheumatol (2012) 0.90
Interstitial fibrosis is associated with increased COL1A2 transcription in AA-injured renal tubular epithelial cells in vivo. Matrix Biol (2011) 0.90
Treatment with an antibody to VLA-1 integrin reduces glomerular and tubulointerstitial scarring in a rat model of crescentic glomerulonephritis. Am J Pathol (2002) 0.90
A spleen tyrosine kinase inhibitor reduces the severity of established glomerulonephritis. J Am Soc Nephrol (2009) 0.90
Rapidly progressive glomerulonephritis: current and evolving treatment strategies. J Nephrol (2004) 0.90
Lymphocytes from P2X7-deficient mice exhibit enhanced P2X7 responses. J Leukoc Biol (2009) 0.89
Long- term outcome of paediatric patients with ANCA vasculitis. Pediatr Rheumatol Online J (2011) 0.87
Pharmacological use of L-carnitine in uremic anemia: has its full potential been exploited? Pharmacol Res (2010) 0.87
Mucosal tolerance induced by an immunodominant peptide from rat alpha3(IV)NC1 in established experimental autoimmune glomerulonephritis. Am J Pathol (2009) 0.87
A nephritogenic peptide induces intermolecular epitope spreading on collagen IV in experimental autoimmune glomerulonephritis. J Am Soc Nephrol (2006) 0.87
Blockade of the CD154-CD40 costimulatory pathway prevents the development of experimental autoimmune glomerulonephritis. Kidney Int (2004) 0.86
Mannose receptor interacts with Fc receptors and is critical for the development of crescentic glomerulonephritis in mice. J Clin Invest (2010) 0.85
B-cell-targeted therapy in adult glomerulonephritis. Expert Opin Biol Ther (2013) 0.84
Microscopic polyangiitis. Semin Respir Crit Care Med (2004) 0.83
Genetic susceptibility to experimental autoimmune glomerulonephritis in the Wistar Kyoto rat. Am J Pathol (2012) 0.83
Retransplantation in Alport post-transplant anti-GBM disease. Kidney Int (2004) 0.83
Blocking VLA-4 prevents progression of experimental crescentic glomerulonephritis. Nephron Exp Nephrol (2003) 0.83
Glomerular T cells are of restricted clonality and express multiple CDR3 motifs across different Vbeta T-cell receptor families in experimental autoimmune glomerulonephritis. Nephron Exp Nephrol (2004) 0.83
Increased incidence of anti-GBM disease in Fcgamma receptor 2b deficient mice, but not mice with conditional deletion of Fcgr2b on either B cells or myeloid cells alone. Mol Immunol (2012) 0.83
Immunology of anti-glomerular basement membrane disease. Curr Opin Nephrol Hypertens (2002) 0.81
Vasculitis: Risks and rewards of treating elderly patients with vasculitis. Nat Rev Nephrol (2011) 0.81
Familial granulomatosis with polyangiitis: three cases of this rare disorder in one Indoasian family carrying an identical HLA DPB1 allele. BMJ Case Rep (2012) 0.81
FcγRIIb on myeloid cells and intrinsic renal cells rather than B cells protects from nephrotoxic nephritis. J Immunol (2012) 0.81
Renal vasculitis--an update in 2004. Nephrol Dial Transplant (2004) 0.81
Elevated Akt phosphorylation as an indicator of renal tubular epithelial cell stress. J Biol Chem (2002) 0.81
Is there a role for TNF-alpha in anti-neutrophil cytoplasmic antibody-associated vasculitis? Lessons from other chronic inflammatory diseases. J Am Soc Nephrol (2006) 0.80
Experimental crescentic glomerulonephritis: a new bicongenic rat model. Dis Model Mech (2013) 0.80
Role of novel rat-specific Fc receptor in macrophage activation associated with crescentic glomerulonephritis. J Biol Chem (2011) 0.80
Reduction of streptavidin RYDS-mediated renal adhesion by site-directed mutagenesis. Biochim Biophys Acta (2002) 0.79
Prolonged B cell depletion with rituximab is effective in treating refractory pulmonary granulomatous inflammation in granulomatosis with polyangiitis (GPA). Medicine (Baltimore) (2014) 0.79
Treatment with a cyclin-dependent kinase inhibitor, seliciclib, is effective in reducing glomerular macrophage numbers and the severity of established experimental glomerulonephritis. Nephrology (Carlton) (2011) 0.78
A patient with suspected miscarriage is found to have hypertension, renal failure, and thrombocytopenia: case outcome. BMJ (2007) 0.78
Should rituximab be used to prevent relapse in patients with ANCA-associated vasculitis? Clin J Am Soc Nephrol (2014) 0.78
Bacterial endocarditis associated with proteinase 3 anti-neutrophil cytoplasm antibody. NDT Plus (2011) 0.78
Aristolochic acid as a causative factor in a case of Chinese herbal nephropathy. Nephrol Dial Transplant (2002) 0.77
Mice with defective Fas ligand are protected from crescentic glomerulonephritis. Kidney Int (2011) 0.77
Platelet-derived growth factor reorganizes the actin cytoskeleton through 3-phosphoinositide-dependent and 3-phosphoinositide-independent mechanisms in human mesangial cells. Nephron Physiol (2007) 0.77
Stimulation of the PD-1/PDL-1 T-cell co-inhibitory pathway is effective in treatment of experimental autoimmune glomerulonephritis. Nephrol Dial Transplant (2011) 0.77
A case of treated ANCA-associated vasculitis with recurrent renal failure. Clin J Am Soc Nephrol (2008) 0.77
Effect of IL-11 on glomerular expression of TGF-beta and extracellular matrix in nephrotoxic nephritis in Wistar Kyoto rats. J Nephrol (2010) 0.76
Antineutrophil cytoplasm antibody-positive pulmonary-renal syndrome in a patient with diffuse cutaneous systemic sclerosis. BMJ Case Rep (2013) 0.75